CRISPR/Cas9 is a programmable genome editing system in which a guide RNA directs the Cas9 nuclease to a specific DNA sequence, where the enzyme…
CRISPR/Cas9 is a programmable genome editing system in which a guide RNA directs the Cas9 nuclease to a specific DNA sequence, where the enzyme…
Antibiotic resistance is the ability of bacteria to survive exposure to drugs designed to kill them or stop their growth.
Bioinformatics and computational biology transform raw genomic data into clinical decisions by integrating advanced algorithms, statistical methods, and biological knowledge to solve problems at scales impossible through traditional laboratory methods alone. These disciplines now form the analytical backbone of precision medicine, enabling researchers and clinicians to identify disease variants, predict treatment responses, and stratify patient populations with unprecedented accuracy.
The convergence of high-throughput sequencing technologies and computational power has fundamentally changed how we approach …
Osteoarthritis gene therapy is advancing from early proof-of-concept studies into multi-site clinical evaluations, with several approaches now testing the durability of pain relief and structural protection in human joints. The therapeutic strategy delivers genetic material directly into affected joints to produce anti-inflammatory proteins, growth factors, or cartilage-protective molecules locally, aiming to modify disease progression rather than simply manage symptoms. This localized gene therapy development …
Genetic testing for lactose intolerance identifies specific DNA variants in the MCM6 gene region that regulate lactase enzyme production, enabling clinicians to distinguish primary lactase non-persistence from other causes of dairy intolerance without the time and patient burden of breath hydrogen or lactose tolerance tests. The test detects single nucleotide polymorphisms associated with continued lactase expression into adulthood, a trait that evolved independently in multiple populations practicing dairy pastoralism. Unlike functional tests that measure current lactase activity, …
Attention-deficit/hyperactivity disorder (ADHD) is among the most heritable psychiatric conditions, with genetic factors accounting for approximately 70-80% of phenotypic variance across populations. This substantial heritability estimate, derived from decades of twin, family, and adoption studies, positions ADHD as a paradigm for understanding how complex polygenic architecture translates into neurodevelopmental outcomes.
The strength of genetic contribution to ADHD exceeds that of most other psychiatric conditions and rivals heritability estimates for traits like height. Yet high heritability does not imply genetic determinism or …
Gene therapy is transitioning from experimental promise to clinical reality in 2026, with recent trial results demonstrating measurable therapeutic outcomes in previously untreatable genetic diseases. The field has reached an inflection point where specific interventions are producing reproducible clinical benefits, regulatory pathways are becoming clearer, and the technical barriers that limited early applications are yielding to refined delivery systems and improved vector designs. For researchers and healthcare professionals tracking therapeutic development, the current landscape demands attention not to distant possibilities but to …
Lactose intolerance is not a genetic mutation in the traditional sense. Rather, it represents the ancestral human condition, where lactase production declines after weaning. The true mutation is lactase persistence, a relatively recent evolutionary adaptation that allows certain populations to digest lactose into adulthood. This distinction fundamentally reframes how we understand the genetics of lactose digestion and challenges common assumptions about what constitutes a genetic “abnormality.”
For researchers and healthcare professionals working in genomics, precision matters. The terminology we use shapes both clinical…
Genetic factors in smoking habits refer to the heritable biological variations that influence an individual’s susceptibility to tobacco initiation, nicotine dependence, and smoking cessation outcomes. These genetic influences operate through multiple pathways, including nicotine metabolism, neurobiological reward systems, and behavioral regulation mechanisms, collectively shaping why some individuals become dependent smokers while others do not despite similar exposure patterns.
Understanding the genetic architecture of smoking behavior has become essential for personalized approaches to tobacco control and cessation …
Yes, secondhand smoke contains nicotine. When tobacco burns, it releases nicotine into both mainstream smoke (exhaled by the smoker) and sidestream smoke (emitted directly from the burning cigarette), creating an environmental exposure that affects nonsmokers through inhalation and dermal absorption. For the genomics community, this confirmation opens a more pressing question: how does nicotine exposure from secondhand smoke interact with individual genetic architecture to influence health outcomes, and what tools can clinicians and researchers use to assess exposure and stratify risk?
Nicotine exposure through secondhand smoke …